According to AlphaMoat, in October 2026 NeuroKaire (neurokaire.com) received 7,746 monthly visits (+1.2% MoM) — ranked #10,613 of 17,609 AI websites with traffic data, and #1,626 of 3,112 in Industry Services; its largest market is United States (100.0% of visits).
NeuroKaire (formerly GenetikaPlus) is dedicated to replacing trial-and-error antidepressant treatment with biological evidence, helping doctors and patients obtain quantifiable biological grounds for medication choice at an earlier stage.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 5.4K | — |
| 2026-07 | 3.0K | -44.7% |
| 2026-08 | 2.6K | -13.1% |
| 2026-09 | 7.7K | +196.6% |
| 2026-10 | 7.7K | +1.2% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, NeuroKaire (neurokaire.com) received 7,746 visits (about 7.7K) in October 2026 (+1.2% month over month), ranking #10,613 of 17,609 AI websites with traffic data, and #1626 in Industry Services.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.